Clinical Laboratory · Nov 1, 2026

Predictive Value of Hemoglobin Glycation Index Combined with TyG-WHtR for Metabolic Syndrome in Middle-Aged and Older Adults

By Lu L, Bai X, Liu Z et al.

BACKGROUND: The aim is to evaluate the predictive performance of the Hemoglobin Glycation Index (HGI) and the triglyceride glucose-waist-to-height ratio (TyG-WHtR), both alone and combined, for Metabolic Syndrome (MetS) in a middle-aged and elderly population. METHODS: A total of 560 subjects aged ≥ 45 years were enrolled from the health examination center and endocrinology outpatient department. MetS was diagnosed using the Adult Treatment Panel III (ATP III) criteria. HGI was calculated based on the linear regression equation of glycated hemoglobin (HbA1c) on fasting plasma glucose (FPG). TyG-WHtR was calculated as the product of the TyG index and waist-to-height ratio (WHtR). Receiver operating characteristic (ROC) curve analysis, the DeLong test, calibration curves, and decision curve analysis (DCA) were used to evaluate the discriminatory ability, calibration, and clinical net benefit of the individual indicators and the combined model. RESULTS: Among the 560 participants, 45.9% were female, and the prevalence of MetS was 38.9%. Multivariate logistic regression identified both HGI and TyG-WHtR as independent predictors of MetS. The areas under the curve (AUC) for predicting MetS were 0.718 for HGI, 0.758 for TyG-WHtR, and 0.826 for the combined model. The combined model demonstrated significantly superior discriminatory ability compared to either single indicator (DeLong test, p < 0.05). The combined model was well-calibrated, and DCA indicated the highest net benefit across a wide range of clinically relevant threshold probabilities. CONCLUSIONS: The combination of HGI and TyG-WHtR significantly improves the predictive performance for MetS in a middle-aged and elderly population. The combined model is well-calibrated and provides high clinical net benefit, offering a practical supplementary tool for the early identification of MetS in health check-up and out-patient settings.

doi.org/10.7754/clin.lab.2025.251051PubMed 43038026Biomarkers

AgingResearch.News